$138.49
1.831.34%
마지막 업데이트: Oct 23, 5:54 AM
Benzinga
Benzinga
Benzinga
금요일, 10월 23
Benzinga
© 2026 Benzinga | All Rights Reserved
Veradermics (MANE) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Estimate | $-0.63 | $-0.79 | $-0.66 |
| Actual | $-0.58 | $-1.32 | $-0.62 |
| Surprise | +7.94% | -67.1% | +6.06% |
| Revenue | |||
| Estimate | — | — | — |
| Actual | $0 | $0 | $0 |
| Surprise | — | — | — |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.61 | $-0.63 |
| Revenue | ||
| Consensus | — | — |
| 회계 분기 | 보고된 날짜 | 실제 EPS | 예상 EPS | 놀라다 % |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $-0.58 | $-0.63 | 7.94 % |
| Q1 | May 12, 2026 | $-1.32 | $-0.79 | -67.1 % |
| Q4 | Mar 30, 2026 | $-0.62 | $-0.66 | 6.06 % |